Skip to main content
. 2024 Oct 15;5(11):1681–1696. doi: 10.1038/s43018-024-00840-y

Table 1.

Demographic and clinical characteristics of the patients

Patient Age decade (gender)a Smoking Genetic ancestry Stage No. of tumors Contralateral/Multilobar Classification
III-1 50s (M) Moderate European 0 >13 Y/Y Germline
III-4 60s (F) Never European 0 10 Y/Y Germline
1 60s (F) Former European IA 4 N/Y Independentc
2 80s (M) Former European IA 3b N/N Metastatic
3 50s (F) Never African IA >3 N/Y Metastatic
4 50s (F) Former Asian IA >5 Y/Y Germline
5 50s (F) Never African IA 5 Y/Y Germline
6 70s (F) Former European IIB 4 N/N Germlinec
7 70s (F) Never European IB 2 N/Y Mosaic
8 80s (F) Former European IA 4 Y/Y Mosaic
9 60s (F) Never European I 4 Y/Y Mosaic
10 70s (F) Former European IA 4 Y/Y Mosaic

aSelf-reported gender.

bAdditional tumors observed on pathological assessment.

cSolely inferred from WES.

Clinical characteristics of two patients from a familial lung cancer pedigree (III-1 and III-4) and ten patients with sporadic multiple primary lung cancers. The stage refers to the clinical impression at the time of surgical resection following the International Association of Small Cell Lung Cancer, 8th edn staging guidelines. The number of tumors corresponds to those observed on CT scans throughout the patient’s lifetime. F, Female; M, Male; N, No; Y, Yes.